Suppr超能文献

对压力性利钠作用的当前认识。

Current Understanding of Pressure Natriuresis.

作者信息

Baek Eun Ji, Kim Sejoong

机构信息

Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

出版信息

Electrolyte Blood Press. 2021 Dec;19(2):38-45. doi: 10.5049/EBP.2021.19.2.38. Epub 2021 Dec 23.

Abstract

Pressure natriuresis refers to the concept that increased renal perfusion pressure leads to a decrease in tubular reabsorption of sodium and an increased sodium excretion. The set point of blood pressure is the point at which pressure natriuresis and extracellular fluid volume are in equilibrium. The term "abnormal pressure natriuresis" usually refers to the expected abnormal effect of a certain level of blood pressure on sodium excretion. Factors that cause abnormal pressure natriuresis are known. Sympathetic nerve system, genetic factors, and dietary factors may affect an increase in renal perfusion pressure. An increase in renal perfusion pressure increases renal interstitial hydrostatic pressure (RIHP). Increased RIHP affects tubular reabsorption through alterations in tight junctional permeability to sodium in proximal tubules, redistribution of apical sodium transporters, and/or release of renal autacoids. Renal autocoids such as nitric oxide, prostaglandin E2, kinins, and angiotensin II may also regulate pressure natriuresis by acting directly on renal tubule sodium transport. In addition, inflammation and reactive oxygen species may mediate pressure natriuresis. Recently, the use of new drugs associated with pressure natriuretic mechanisms, such as angiotensin receptor neprilysin inhibitor and sodium glucose co-transporter 2 inhibitors, has been consistently demonstrated to reduce mortality and hypertension-related complications. Therefore, the understanding of pressure natriuresis is gaining attention as an antihypertensive strategy. In this review, we provide a basic overview of pressure natriuresis to the target audience of nephrologists.

摘要

压力性利钠是指这样一种概念,即肾灌注压升高会导致肾小管对钠的重吸收减少以及钠排泄增加。血压的设定点是压力性利钠与细胞外液量处于平衡的点。“异常压力性利钠”一词通常指一定血压水平对钠排泄的预期异常影响。导致异常压力性利钠的因素是已知的。交感神经系统、遗传因素和饮食因素可能影响肾灌注压升高。肾灌注压升高会增加肾间质静水压(RIHP)。RIHP升高通过改变近端小管紧密连接对钠的通透性、顶端钠转运体的重新分布和/或肾自分泌物质的释放来影响肾小管重吸收。一氧化氮、前列腺素E2、激肽和血管紧张素II等肾自分泌物质也可能通过直接作用于肾小管钠转运来调节压力性利钠。此外,炎症和活性氧可能介导压力性利钠。最近,与压力性利钠机制相关的新药,如血管紧张素受体脑啡肽酶抑制剂和钠-葡萄糖协同转运蛋白2抑制剂的使用,已被一致证明可降低死亡率和高血压相关并发症。因此,对压力性利钠的理解作为一种降压策略正受到关注。在本综述中,我们向肾病学家这一目标受众提供压力性利钠的基本概述。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验